CHAMPIONS ONCOLOGY, INC.

Nasdaq:CSBR

Biological Products, (No Diagnostic Substances)·BALTIMORE, MD

Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients.

CEO

Brainin Robert Lawrence

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q1 2026	1/31/26	3/12/26	→
10-Q	Q4 2025	10/31/25	12/15/25	→
10-Q	Q3 2025	7/31/25	9/15/25	→
10-K	FY 2025	4/30/25	7/23/25	→
10-Q	Q1 2025	1/31/25	3/17/25	→
10-Q	Q4 2024	10/31/24	12/16/24	→
↓

Earnings Releases (8-K)

42 shown

Filed	Period
3/12/26	Q4 FY2026	→
12/15/25	Q3 FY2026	→
9/15/25	Q2 FY2026	→
7/23/25	Q1 FY2026	→
3/11/25	Q4 FY2025	→
12/11/24	Q3 FY2025	→
↓

News (8-K)

38 shown

Filed	Type	Description
10/16/25	Vote	Submission of Matters to a Vote of Security Holders	→
7/21/25	Other	8-K Filing	→
10/15/24	Vote	Submission of Matters to a Vote of Security Holders	→
10/3/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/19/23	Vote	Submission of Matters to a Vote of Security Holders	→
10/17/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

8 shown

Filed	Form	Description
10/30/24	S-8	S-8	→
6/10/16	424B4	424B4	→
5/24/16	S-1/A	S-1/A	→
4/26/16	S-1	S-1	→
10/15/15	424B3	424B3	→
5/19/15	424B3	424B3	→
↓

Filing History(646 filings)

TypeDateAccessionPeriodSize

10-Q

Mar 12, 2026

0001628280-26-01734510-Q

Jan 31, 2026

5.3 MB

8-K

Mar 12, 2026

0001628280-26-0172598-K

Mar 12, 2026

401.5 KB

Jan 30, 2026

0001628280-26-004381FORM 4

Jul 16, 2025

16.8 KB

Jan 30, 2026

0001628280-26-004342FORM 4

Nov 5, 2021

12.0 KB

Jan 16, 2026

0001628280-26-002423FORM 3

Jun 9, 2021

4.5 KB

10-Q

Dec 15, 2025

0001628280-25-05708210-Q

Oct 31, 2025

5.3 MB

8-K

Dec 15, 2025

0001628280-25-0570208-K

Dec 15, 2025

407.0 KB

Nov 7, 2025

0001628280-25-050522FORM 4

Nov 5, 2025

5.5 KB

Nov 7, 2025

0001628280-25-050514FORM 4

Nov 5, 2025

5.5 KB

Nov 7, 2025

0001628280-25-050491FORM 4

Nov 5, 2025

5.6 KB

Nov 7, 2025

0001628280-25-050481FORM 4

Nov 5, 2025

5.5 KB

Nov 7, 2025

0001628280-25-050467FORM 4

Nov 5, 2025

5.6 KB

Nov 6, 2025

0001628280-25-049954FORM 4

Oct 30, 2025

6.9 KB

8-K

Oct 16, 2025

0001628280-25-0452418-K

Oct 16, 2025

173.5 KB

10-Q

Sep 15, 2025

0000771856-25-00002310-Q

Jul 31, 2025

4.8 MB

8-K

Sep 15, 2025

0000771856-25-0000228-K

Sep 15, 2025

349.3 KB

DEFA14A

Aug 22, 2025

0000771856-25-000010DEFA14A

—

36.3 KB

DEF 14A

Aug 22, 2025

0000771856-25-000009DEF 14A

Aug 22, 2025

1.3 MB

10-K

Jul 23, 2025

0001628280-25-03576510-K

Apr 30, 2025

6.2 MB

8-K

Jul 23, 2025

0001628280-25-0357278-K

Jul 23, 2025

383.1 KB

8-K

Jul 21, 2025

0001628280-25-0354248-K

Jul 21, 2025

329.0 KB

Apr 2, 2025

0001628280-25-016197FORM 4

Mar 25, 2025

4.8 KB

10-Q

Mar 17, 2025

0001628280-25-01294110-Q

Jan 31, 2025

4.8 MB

8-K

Mar 11, 2025

0001628280-25-0120228-K

Mar 11, 2025

373.5 KB

UPLOAD

Mar 4, 2025

0000000000-25-002410

—

39.1 KB

25 filings shown

Filed	Form	Description
2/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/9/16	EFFECT	EFFECT	→
10/13/15	EFFECT	EFFECT	→
9/25/15	POS AM	POS AM	→
8/20/15	CERTNAS	AUTO-GENERATED PAPER DOCUMENT	→
8/20/15	8-A12B	FORM 8-A12B	→
↓

CHAMPIONS ONCOLOGY, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(646 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
8/22/25	DEFA14A	DEFA14A	→
8/22/25	DEF 14A	DEF 14A	→
8/27/24	DEFA14A	DEFA14A	→
8/27/24	DEF 14A	DEF 14A	→
8/28/23	DEFA14A	DEFA14A	→
8/28/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
1/30/26	4	4	→
1/30/26	4	4	→
1/16/26	3	FORM 3	→
11/7/25	4	4	→
11/7/25	4	4	→
11/7/25	4	4	→
↓